Literature DB >> 15549520

Coagulation abnormalities in migraine and ischaemic cerebrovascular disease: a link between migraine and ischaemic stroke?

F Moschiano1, D D'Amico, E Ciusani, N Erba, A Rigamonti, F Schieroni, G Bussone.   

Abstract

Migraine, particularly migraine with aura, is a risk factor for ischaemic stroke. The mechanisms underlying this association are obscure. One hypothesis is that shared risk factors may be the cause of this association. Over the last decade, studies have suggested an association between migraine and genetic abnormalities in coagulation factors which play an important role in stroke pathogenesis. Although the results of studies on various prothrombotic conditions are conflicting, findings suggest a higher frequency of some genetic abnormalities in migraine with aura patients. Thus, persistent hypercoagulability may explain the tendency for these patients to develop thromboembolic cerebrovascular events, especially when they are exposed to additional procoagulant stresses. Further studies on larger samples are required to test this hypothesis.

Entities:  

Mesh:

Year:  2004        PMID: 15549520     DOI: 10.1007/s10072-004-0269-5

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  4 in total

Review 1.  Migraine and stroke: from a questioned relationship to a supported comorbidity.

Authors:  Maria Carola Narbone; Santo Gangemi; Maria Abbate
Journal:  Neurol Sci       Date:  2008-05       Impact factor: 3.307

2.  Risk factors for ischemic stroke and transient ischemic attack in patients under age 50.

Authors:  A W M Janssen; F E de Leeuw; M C H Janssen
Journal:  J Thromb Thrombolysis       Date:  2011-01       Impact factor: 2.300

3.  An unusual case report on the possible role of Warfarin in migraine prophylaxis.

Authors:  Angelo Russo; Sara Santi; Daniela Gueraldi; Maria De Paola; Fabiana Zani; Luigi Alberto Pini
Journal:  Springerplus       Date:  2013-02-12

Review 4.  The Migraine-Stroke Connection.

Authors:  Mi Ji Lee; Chungbin Lee; Chin-Sang Chung
Journal:  J Stroke       Date:  2016-05-31       Impact factor: 6.967

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.